Each bottle ofVelsipity willcontain______tabletsVelsipity isindicated fortreating___________TherecommendeddoseofVelsipity is______Themechanismof action ofVelsipity is___________State one pre-treatmentserviceavailable topatients______Some patientsrequire a__________thefirst time theytake Velsipity_________willadvise the CWif the patientmeets bridgingcriteriaVelsipity isadministeredvia_______________________isa very commonadverse reactionList onesymptom ofUC_________Patients shouldnot_______theirdose of Velsipityto make up for aforgotten doseLong-termbridging may beapproved for_______monthsThe genericname ofVelsipity is___________Patients with_________should haveregular eyeexamsOnecommonside effect ofVelsipity is_________If more than___consecutivedoses are missednotify HCP fortreatment re-initiationEach blisterpack ofVelsipitycontains_____or_____tabletsVelsipity hassimilarprogramofferings to____________Patientswith__________should haveregular eyeexamsThe Velsipitywelcome call isperformedby__________FCM mustescalate to______forapproval if apatient does notmeet criteriaUC is a chronicinflammatorydisease thataffectsthe________Anothercommon sideeffect of Velsipityis_____________Velsipityshould bestored at___________Each bottle ofVelsipity willcontain______tabletsVelsipity isindicated fortreating___________TherecommendeddoseofVelsipity is______Themechanismof action ofVelsipity is___________State one pre-treatmentserviceavailable topatients______Some patientsrequire a__________thefirst time theytake Velsipity_________willadvise the CWif the patientmeets bridgingcriteriaVelsipity isadministeredvia_______________________isa very commonadverse reactionList onesymptom ofUC_________Patients shouldnot_______theirdose of Velsipityto make up for aforgotten doseLong-termbridging may beapproved for_______monthsThe genericname ofVelsipity is___________Patients with_________should haveregular eyeexamsOnecommonside effect ofVelsipity is_________If more than___consecutivedoses are missednotify HCP fortreatment re-initiationEach blisterpack ofVelsipitycontains_____or_____tabletsVelsipity hassimilarprogramofferings to____________Patientswith__________should haveregular eyeexamsThe Velsipitywelcome call isperformedby__________FCM mustescalate to______forapproval if apatient does notmeet criteriaUC is a chronicinflammatorydisease thataffectsthe________Anothercommon sideeffect of Velsipityis_____________Velsipityshould bestored at___________

Velsipity BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Each bottle of Velsipity will contain ______tablets
  2. Velsipity is indicated for treating ___________
  3. The recommended doseof Velsipity is ______
  4. The mechanism of action of Velsipity is ___________
  5. State one pre-treatment service available to patients______
  6. Some patients require a __________the first time they take Velsipity
  7. _________will advise the CW if the patient meets bridging criteria
  8. Velsipity is administered via ___________
  9. ____________is a very common adverse reaction
  10. List one symptom of UC_________
  11. Patients should not _______their dose of Velsipity to make up for a forgotten dose
  12. Long-term bridging may be approved for _______months
  13. The generic name of Velsipity is ___________
  14. Patients with _________ should have regular eye exams
  15. One common side effect of Velsipity is _________
  16. If more than ___consecutive doses are missed notify HCP for treatment re-initiation
  17. Each blister pack of Velsipity contains _____or _____tablets
  18. Velsipity has similar program offerings to ____________
  19. Patients with__________ should have regular eye exams
  20. The Velsipity welcome call is performed by__________
  21. FCM must escalate to ______for approval if a patient does not meet criteria
  22. UC is a chronic inflammatory disease that affects the________
  23. Another common side effect of Velsipity is _____________
  24. Velsipity should be stored at ___________